Homophilic Adhesion and CEACAM1-S Regulate Dimerization of CEACAM1-L and Recruitment of SHP-2 and C-Src

Overview

Journal J Cell Biol

Specialty Cell Biology

Date 2009 Dec 2

PMID 19948503

Citations 41

Authors

Mario M Muller

Esther Klaile

Olga Vorontsova

Bernhard B Singer

Bjorn Obrink

Affiliations

Soon will be listed here.

Abstract

Carcinoembryonic antigen (CEA)-related cell adhesion molecule 1 (CAM1 [CEACAM1]) mediates homophilic cell adhesion and regulates signaling. Although there is evidence that CEACAM1 binds and activates SHP-1, SHP-2, and c-Src, knowledge about the mechanism of transmembrane signaling is lacking. To analyze the regulation of SHP-1/SHP-2/c-Src binding, we expressed various CFP/YFP-tagged CEACAM1 isoforms in epithelial cells. The supramolecular organization of CEACAM1 was examined by cross-linking, coclustering, coimmunoprecipitation, and fluorescence resonance energy transfer. SHP-1/SHP-2/c-Src binding was monitored by coimmunoprecipitation and phosphotyrosine-induced recruitment to CEACAM1-L in cellular monolayers. We find that trans-homophilic CEACAM1 binding induces cis-dimerization by an allosteric mechanism transmitted by the N-terminal immunoglobulin-like domain. The balance of SHP-2 and c-Src binding is dependent on the monomer/dimer equilibrium of CEACAM1-L and is regulated by trans-binding, whereas SHP-1 does not bind under physiological conditions. CEACAM1-L homodimer formation is reduced by coexpression of CEACAM1-S and modulated by antibody ligation. These data suggest that transmembrane signaling by CEACAM1 operates by alteration of the monomer/dimer equilibrium, which leads to changes in the SHP-2/c-Src-binding ratio.

Citing Articles

The role of CEACAMs in neutrophil function.

Skubitz K Eur J Clin Invest. 2024; 54 Suppl 2:e14349.

PMID: 39674879 PMC: 11646290. DOI: 10.1111/eci.14349.

CEACAM1 in vascular homeostasis and inflammation.

Gotz L, Rueckschloss U, Ergun S, Kleefeldt F Eur J Clin Invest. 2024; 54 Suppl 2:e14345.

PMID: 39674877 PMC: 11646292. DOI: 10.1111/eci.14345.

Carcinoembryonic antigen-related cell adhesion molecule 1 in cancer: Blessing or curse?.

Gotz L, Rueckschloss U, Najjar S, Ergun S, Kleefeldt F Eur J Clin Invest. 2024; 54 Suppl 2:e14337.

PMID: 39451132 PMC: 11646294. DOI: 10.1111/eci.14337.

The role of carcinoembryonic antigen-related cell adhesion molecule 1 in cancer.

Gotz L, Rueckschloss U, Balk G, Pfeiffer V, Ergun S, Kleefeldt F Front Immunol. 2023; 14:1295232.

PMID: 38077351 PMC: 10704240. DOI: 10.3389/fimmu.2023.1295232.

Effects of adhesin HopQ binding to CEACAM receptors in the human stomach.

Nguyen Q, Schmitt L, Mejias-Luque R, Gerhard M Front Immunol. 2023; 14:1113478.

PMID: 36891299 PMC: 9986547. DOI: 10.3389/fimmu.2023.1113478.

References

Muller M, Singer B, Klaile E, Obrink B, Lucka L . Transmembrane CEACAM1 affects integrin-dependent signaling and regulates extracellular matrix protein-specific morphology and migration of endothelial cells. Blood. 2005; 105(10):3925-34. DOI: 10.1182/blood-2004-09-3618. View

Nagaishi T, Pao L, Lin S, Iijima H, Kaser A, Qiao S . SHP1 phosphatase-dependent T cell inhibition by CEACAM1 adhesion molecule isoforms. Immunity. 2006; 25(5):769-81. DOI: 10.1016/j.immuni.2006.08.026. View

Horst A, Ito W, Dabelstein J, Schumacher U, Sander H, Turbide C . Carcinoembryonic antigen-related cell adhesion molecule 1 modulates vascular remodeling in vitro and in vivo. J Clin Invest. 2006; 116(6):1596-605. PMC: 1448166. DOI: 10.1172/JCI24340. View

Gray-Owen S, Blumberg R . CEACAM1: contact-dependent control of immunity. Nat Rev Immunol. 2006; 6(6):433-46. DOI: 10.1038/nri1864. View

Brummer J, Neumaier M, Gopfert C, Wagener C . Association of pp60c-src with biliary glycoprotein (CD66a), an adhesion molecule of the carcinoembryonic antigen family downregulated in colorectal carcinomas. Oncogene. 1995; 11(8):1649-55. View

Obrink B, Sawa H, Scheffrahn I, Singer B, Sigmundsson K, Sundberg U . Computational analysis of isoform-specific signal regulation by CEACAM1-A cell adhesion molecule expressed in PC12 cells. Ann N Y Acad Sci. 2002; 971:597-607. DOI: 10.1111/j.1749-6632.2002.tb04536.x. View

Obrink B . CEA adhesion molecules: multifunctional proteins with signal-regulatory properties. Curr Opin Cell Biol. 1997; 9(5):616-26. PMC: 7135799. DOI: 10.1016/s0955-0674(97)80114-7. View

Beauchemin N, Draber P, Dveksler G, Gold P, Grunert F, Hammarstrom S . Redefined nomenclature for members of the carcinoembryonic antigen family. Exp Cell Res. 2001; 252(2):243-9. DOI: 10.1006/excr.1999.4610. View

Poole A, Jones M . A SHPing tale: perspectives on the regulation of SHP-1 and SHP-2 tyrosine phosphatases by the C-terminal tail. Cell Signal. 2005; 17(11):1323-32. DOI: 10.1016/j.cellsig.2005.05.016. View

10.

Hunter I, Sawa H, Edlund M, Obrink B . Evidence for regulated dimerization of cell-cell adhesion molecule (C-CAM) in epithelial cells. Biochem J. 1996; 320 ( Pt 3):847-53. PMC: 1218006. DOI: 10.1042/bj3200847. View

11.

Singer B, Klaile E, Scheffrahn I, Muller M, Kammerer R, Reutter W . CEACAM1 (CD66a) mediates delay of spontaneous and Fas ligand-induced apoptosis in granulocytes. Eur J Immunol. 2005; 35(6):1949-59. DOI: 10.1002/eji.200425691. View

12.

Olsson H, Wikstrom K, Kjellstrom G, Obrink B . Cell adhesion activity of the short cytoplasmic domain isoform of C-CAM (C-CAM2) in CHO cells. FEBS Lett. 1995; 365(1):51-6. DOI: 10.1016/0014-5793(95)00436-d. View

13.

Craggs G, Kellie S . A functional nuclear localization sequence in the C-terminal domain of SHP-1. J Biol Chem. 2001; 276(26):23719-25. DOI: 10.1074/jbc.M102846200. View

14.

Edlund M, Gaardsvoll H, Bock E, Obrink B . Different isoforms and stock-specific variants of the cell adhesion molecule C-CAM (cell-CAM 105) in rat liver. Eur J Biochem. 1993; 213(3):1109-16. DOI: 10.1111/j.1432-1033.1993.tb17860.x. View

15.

Kirshner J, Chen C, Liu P, Huang J, Shively J . CEACAM1-4S, a cell-cell adhesion molecule, mediates apoptosis and reverts mammary carcinoma cells to a normal morphogenic phenotype in a 3D culture. Proc Natl Acad Sci U S A. 2003; 100(2):521-6. PMC: 141028. DOI: 10.1073/pnas.232711199. View

16.

Kim M, Carman C, Springer T . Bidirectional transmembrane signaling by cytoplasmic domain separation in integrins. Science. 2003; 301(5640):1720-5. DOI: 10.1126/science.1084174. View

17.

Gaur S, Shively J, Yen Y, Gaur R . Altered splicing of CEACAM1 in breast cancer: identification of regulatory sequences that control splicing of CEACAM1 into long or short cytoplasmic domain isoforms. Mol Cancer. 2008; 7:46. PMC: 2490704. DOI: 10.1186/1476-4598-7-46. View

18.

Yokoyama S, Chen C, Nguyen T, Shively J . Role of CEACAM1 isoforms in an in vivo model of mammary morphogenesis: mutational analysis of the cytoplasmic domain of CEACAM1-4S reveals key residues involved in lumen formation. Oncogene. 2007; 26(55):7637-46. DOI: 10.1038/sj.onc.1210577. View

19.

Huber M, Izzi L, Grondin P, Houde C, Kunath T, Veillette A . The carboxyl-terminal region of biliary glycoprotein controls its tyrosine phosphorylation and association with protein-tyrosine phosphatases SHP-1 and SHP-2 in epithelial cells. J Biol Chem. 1998; 274(1):335-44. DOI: 10.1074/jbc.274.1.335. View

20.

Ebrahimnejad A, Streichert T, Nollau P, Horst A, Wagener C, Bamberger A . CEACAM1 enhances invasion and migration of melanocytic and melanoma cells. Am J Pathol. 2004; 165(5):1781-7. PMC: 1618678. DOI: 10.1016/S0002-9440(10)63433-5. View